From Donation to Therapy: An Examination of the Market
Factor VIII is a specific protein found in blood plasma that plays a crucial role in the blood clotting process. For people with Hemophilia A, the most common form of hemophilia, this protein is either missing or present in insufficient quantities. Without it, even a small cut can lead to severe and prolonged bleeding. Plasma-derived Factor VIII concentrates are a life-saving therapy that provides this missing protein, giving patients the ability to clot their blood normally. The development of this treatment has been a game-changer, allowing patients to lead a relatively normal life, free from the constant threat of a bleeding crisis. The ability to isolate and concentrate this specific protein from donated plasma is a scientific and medical triumph. This essential treatment is a cornerstone of the Blood Plasma Derivatives Market.